UPDATE: Credit Suisse Raises PT On HCA Holdings On 2015 EBITDA Estimate

In a report published Thursday, Credit Suisse analyst Ralph Giacobbe reiterated an Outperform rating on

, and raised the price target from $81.00 to $83.00. In the report, Credit Suisse noted, “We are increasing our TP for HCA to $83 (from $81), which pegs a ~9x multiple on our 2015 EBITDA estimate. We maintain our Outperform rating on shares of HCA. Please see our 1/8/15 note, ‘Don't Sell 'Em Short as Year 2 of Reform Should Pack Healthy Punch' for more details.” HCA Holdings closed on Wednesday at $72.99.